{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:24:49Z","timestamp":1791059089294,"version":"4.1.0"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T00:00:00Z","timestamp":1335484800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0035462","type":"journal-article","created":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T21:20:40Z","timestamp":1335561640000},"page":"e35462","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":82,"title":["Candidate Proteins, Metabolites and Transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study"],"prefix":"10.1371","volume":"7","author":[{"given":"Richard S.","family":"Finkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas O.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Swoboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Juhasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca H.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Trachtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne J.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dione T.","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia L.","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Plasterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Pilot Study of Biomarkers for Spinal Muscular Atrophy (BforSMA) Trial Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,4,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/jmg.15.6.409","article-title":"Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.","volume":"15","author":"J Pearn","year":"1978","journal-title":"J Med Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.","volume":"70","author":"M Feldkotter","year":"2002","journal-title":"Am J Hum Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.nurt.2008.08.007","article-title":"Spinal muscular atrophy.","volume":"5","author":"M Oskoui","year":"2008","journal-title":"Neurotherapeutics"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00439-006-0245-7","article-title":"Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts.","volume":"120","author":"VB Mattis","year":"2006","journal-title":"Hum Genet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5ra12","DOI":"10.1126\/scitranslmed.3000208","article-title":"Tetracyclines that promote SMN2 exon 7 splicing as therapeutics for spinal muscular atrophy.","volume":"1","author":"ML Hastings","year":"2009","journal-title":"Sci Transl Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","article-title":"Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy.","volume":"3","author":"MA Passini","year":"2011","journal-title":"Sci Transl Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI41615","article-title":"CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.","volume":"120","author":"MA Passini","year":"2010","journal-title":"J Clin Invest"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN.","volume":"28","author":"KD Foust","year":"2010","journal-title":"Nat Biotechnol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"35ra42","DOI":"10.1126\/scitranslmed.3000830","article-title":"Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy.","volume":"2","author":"CF Valori","year":"2010","journal-title":"Sci Transl Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/ddq514","article-title":"Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.","volume":"20","author":"E Dominguez","year":"2011","journal-title":"Hum Mol Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/01.wnl.0000249142.82285.d6","article-title":"Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy.","volume":"68","author":"E Mercuri","year":"2007","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nmd.2003.11.006","article-title":"Pilot trial of phenylbutyrate in spinal muscular atrophy.","volume":"14","author":"E Mercuri","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jns.2007.11.012","article-title":"The effect of hydroxyurea in spinal muscular atrophy cells and patients.","volume":"268","author":"WC Liang","year":"2008","journal-title":"J Neurol Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e5268","DOI":"10.1371\/journal.pone.0005268","article-title":"Phase II open label study of valproic acid in spinal muscular atrophy.","volume":"4","author":"KJ Swoboda","year":"2009","journal-title":"PLoS ONE"},{"key":"ref15","first-page":"291","article-title":"Progress and promise: the current status of spinal muscular atrophy therapeutics.","volume":"12","author":"JP Van Meerbeke","year":"2011","journal-title":"Discov Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1177\/0883073807305665","article-title":"Perspectives on clinical trials in spinal muscular atrophy.","volume":"22","author":"KJ Swoboda","year":"2007","journal-title":"J Child Neurol"},{"key":"ref17","first-page":"20103731","article-title":"Observational Study of Spinal Muscular Atrophy Type 2 and 3: Functional Outcomes Over 1 Year.","volume":"0","author":"P Kaufmann","year":"2011","journal-title":"Arch Neurol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.nmd.2004.04.004","article-title":"Concerns about the design of clinical trials for spinal muscular atrophy.","volume":"14","author":"TO Crawford","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0092-8674(00)81632-3","article-title":"A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing.","volume":"95","author":"L Pellizzoni","year":"1998","journal-title":"Cell"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/ncb1101-945","article-title":"A multiprotein complex mediates the ATP-dependent assembly of spliceosomal U snRNPs.","volume":"3","author":"G Meister","year":"2001","journal-title":"Nat Cell Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1093\/hmg\/8.13.2351","article-title":"Essential role for the tudor domain of SMN in spliceosomal U snRNP assembly: implications for spinal muscular atrophy.","volume":"8","author":"D Buhler","year":"1999","journal-title":"Hum Mol Genet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0092-8674(00)80368-2","article-title":"The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis.","volume":"90","author":"U Fischer","year":"1997","journal-title":"Cell"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1073\/pnas.0812937106","article-title":"Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis.","volume":"106","author":"JE Landers","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cell.2009.03.006","article-title":"Rethinking ALS: the FUS about TDP-43.","volume":"136","author":"C Lagier-Tourenne","year":"2009","journal-title":"Cell"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/hmg\/ddp134","article-title":"Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery.","volume":"18","author":"M de Planell-Saguer","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mus.21428","article-title":"RNA processing defects associated with diseases of the motor neuron.","volume":"41","author":"SJ Kolb","year":"2010","journal-title":"Muscle Nerve"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1021\/pr0606530","article-title":"The art and practice of systems biology in medicine: mapping patterns of relationships.","volume":"6","author":"J van der Greef","year":"2007","journal-title":"J Proteome Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/01.wnl.0000333251.36681.a5","article-title":"A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.","volume":"72","author":"RM Mitchell","year":"2009","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1653","article-title":"Classification and prediction of clinical Alzheimer\u2019s diagnosis based on plasma signaling proteins.","volume":"13","author":"S Ray","year":"2007","journal-title":"Nat Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/17482960801933942","article-title":"Oxidative stress biomarkers in sporadic ALS.","volume":"9","author":"H Mitsumoto","year":"2008","journal-title":"Amyotroph Lateral Scler"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11306-005-4810-1","article-title":"Metabolomic analysis and signatures in motor neuron disease.","volume":"1","author":"S Rozen","year":"2005","journal-title":"Metabolomics"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10048-008-0167-8","article-title":"Gene expression in blood of subjects with Duchenne muscular dystrophy.","volume":"10","author":"B Wong","year":"2009","journal-title":"Neurogenetics"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11306-005-4810-1","article-title":"Metabolomic analysis and signatures in motor neuron disease.","volume":"1","author":"S Rozen","year":"2005","journal-title":"Metabolomics"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbrc.2006.02.051","article-title":"Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson\u2019s disease.","volume":"342","author":"IL Goldknopf","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/brain\/awl027","article-title":"Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles.","volume":"129","author":"BR Underwood","year":"2006","journal-title":"Brain"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1093\/brain\/awl279","article-title":"Proteome-based plasma biomarkers for Alzheimer\u2019s disease.","volume":"129","author":"A Hye","year":"2006","journal-title":"Brain"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1373\/clinchem.2005.053090","article-title":"High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures.","volume":"51","author":"MF Lopez","year":"2005","journal-title":"Clin Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1039\/b708489g","article-title":"Correlation network analysis for data integration and biomarker selection.","volume":"4","author":"A Adourian","year":"2008","journal-title":"Mol Biosyst"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.nmd.2006.03.015","article-title":"A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy.","volume":"16","author":"KJ Krosschell","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0960-8966(95)00032-1","article-title":"Spinal muscular atrophy. 32nd ENMC International Workshop. Naarden, The Netherlands, 10\u201312 March 1995.","volume":"6","author":"T Munsat","year":"1996","journal-title":"Neuromuscul Disord"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0960-8966(99)00016-4","article-title":"59th ENMC International Workshop: Spinal Muscular Atrophies: recent progress and revised diagnostic criteria 17\u201319 April 1998, Soestduinen, The Netherlands.","volume":"9","author":"K Zerres","year":"1999","journal-title":"Neuromuscul Disord"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and variable selection via the elastic net.","volume":"67","author":"H Zou","year":"2005","journal-title":"J R Statist Soc B"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1090-3798(03)00060-6","article-title":"The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation.","volume":"7","author":"M Main","year":"2003","journal-title":"Eur J Paediatr Neurol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/1467-9868.00346","article-title":"A direct approach to false discovery rates.","volume":"64","author":"J Storey","year":"2002","journal-title":"J R Statist Soc B"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1074\/mcp.M400129-MCP200","article-title":"Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents.","volume":"3","author":"PL Ross","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/pr100659e","article-title":"Semi-targeted plasma proteomics discovery workflow utilizing two-stage protein depletion and off-line LC-MALDI MS\/MS.","volume":"10","author":"P Juhasz","year":"2011","journal-title":"J Proteome Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1074\/mcp.M800008-MCP200","article-title":"Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy.","volume":"7","author":"WJ Qian","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.","volume":"3","author":"J Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/nar\/gng015","article-title":"Summaries of Affymetrix GeneChip probe level data.","volume":"31","author":"RA Irizarry","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing.","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"JR Statist Soc B"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/omi.2004.8.267","article-title":"Methods for the differential integrative omic analysis of plasma from a transgenic disease animal model.","volume":"8","author":"E Davidov","year":"2004","journal-title":"OMICS"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2165\/00822942-200403040-00002","article-title":"Phenotype characterisation using integrated gene transcript, protein and metabolite profiling.","volume":"3","author":"M Oresic","year":"2004","journal-title":"Appl Bioinformatics"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/153623104773547453","article-title":"Integrative biological analysis of the APOE*3-leiden transgenic mouse.","volume":"8","author":"CB Clish","year":"2004","journal-title":"OMICS"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0192623308329287","article-title":"The liver toxicity biomarker study: phase I design and preliminary results.","volume":"37","author":"RN McBurney","year":"2009","journal-title":"Toxicol Pathol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","article-title":"The neurobiology of childhood spinal muscular atrophy.","volume":"3","author":"TO Crawford","year":"1996","journal-title":"Neurobiol Dis"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene.","volume":"80","author":"S Lefebvre","year":"1995","journal-title":"Cell"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0092-8674(95)90461-1","article-title":"The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy.","volume":"80","author":"N Roy","year":"1995","journal-title":"Cell"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0883073807305664","article-title":"Congenital bone fractures in spinal muscular atrophy: functional role for SMN protein in bone remodeling.","volume":"22","author":"S Shanmugarajan","year":"2007","journal-title":"J Child Neurol"},{"key":"ref59","doi-asserted-by":"crossref","DOI":"10.1111\/j.1469-8749.2011.03939.x","article-title":"Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy.","author":"A Mayhew","year":"2011"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/annonc\/mdq432","article-title":"EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer.","volume":"22","author":"IJ Dahabreh","year":"2011","journal-title":"Ann Oncol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"e33572","DOI":"10.1371\/journal.pone.0033572","article-title":"Evaluation of SMN Protein, Transcript, and Copy Number in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study.","volume":"7(4)","author":"TO Crawford","year":"2012","journal-title":"PLoS ONE"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0035462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:04:48Z","timestamp":1713917088000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0035462"}},"subtitle":[],"editor":[{"given":"Christoph","family":"Winkler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,27]]},"references-count":61,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0035462","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,27]]}}}